Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. Yin
Observed name:
Junwei Yin
Institution:
First Affiliated Hospital of Xinxiang Medical University
Observed institutions:
University of Electronic Science and Technology of China,
First Affiliated Hospital of Xinxiang Medical University,
Sichuan Cancer Hospital,
Takeda (United States)
ORCID:
0009-0004-5365-9658
Observed ORCID:
0009-0004-5365-9658
OpenAlex ID:
A5009475371
319O ALTA-3: A randomized trial of brigatinib (BRG) vs alectinib (ALC) in crizotinib (CRZ)-refractory advanced ALK+ NSCLC
2022
·
J.C-H. Yang
, G. Liu
, et al.
·
Annals of Oncology
·
10
Efficacy of transarterial chemoembolization combined with radiofrequency ablation in the treatment of liver metastases from colorectal cancer
2025
·
Junwei Yin
, Yongli Zhao
, et al.
·
Clinical & Translational Oncology
Preliminary Analysis of Concurrent Programmed Cell Death-1 Inhibitor Combination with Chemoradiation for Recurrent/Metastatic Nasopharyngeal Carcinoma Patients: A Phase II Study
2022
·
M. Feng
, L. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
3
Citation count:
10
H-index:
1
I10-index:
1
Year
Topic
Type